Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used intravenously to halt premature labor. Although initial studies suggested it could be used as a nasal spray and hence would not require hospital admission, it is not used in that form. Atobisan was developed by the Swedish company Ferring Pharmaceuticals. It was first reported in t...
Atosiban is indicated for use in delaying imminent pre-term birth in pregnant adult women with:
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.